• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TG Therapeutics, Inc. - Common Stock (NQ:TGTX)

34.14 -0.08 (-0.23%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,218,393
Open 33.86
Bid (Size) 34.00 (4)
Ask (Size) 34.77 (20)
Prev. Close 34.22
Today's Range 33.59 - 34.78
52wk Range 21.82 - 46.48
Shares Outstanding 154,420,772
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
TG THERAPEUTICS INC (NASDAQ:TGTX) Shows High Growth Momentum and Technical Breakout Setup
October 07, 2025
TG Therapeutics (TGTX) shows explosive EPS growth up to 1,300% and strong sales momentum. With a perfect 10 technical rating and a bullish chart setup, it's a high-growth stock to watch. 
Via Chartmill
10 Health Care Stocks Whale Activity In Today's Session
October 01, 2025
 
Via Benzinga

Performance

YTD
+9.9%
+9.9%
1 Month
+7.5%
+7.5%
3 Month
-12.3%
-12.3%
6 Month
-11.1%
-11.1%
1 Year
+49.5%
+49.5%

More News

Read More
TG Therapeutics CEO Voices Strong Conviction In Briumvi With New $100 Million Buyback
September 03, 2025
Via Benzinga
TG Therapeutics Board Authorizes New $100M Share Repurchase Program
September 03, 2025
Via Stocktwits
TG Therapeutics Stock Tumbles 15% After Disappointing Q2, But Company Reaffirms Confidence In Multiple Sclerosis Drug
August 04, 2025
Via Stocktwits
Topics Earnings
Earnings Scheduled For August 4, 2025
August 04, 2025
Via Benzinga
What's Next: TG Therapeutics's Earnings Preview
August 01, 2025
Via Benzinga
Earnings Scheduled For May 5, 2025
May 05, 2025
Via Benzinga
Crude Oil Falls 1.5%; ON Semiconductor Shares Plunge After Q2 Results
August 04, 2025
Via Benzinga
Briumvi's Strong Sales Can't Stop TG Therapeutics Stock Slide
August 04, 2025
Via Benzinga
TG Therapeutics Q2 Revenue Up 91%
August 04, 2025
Via The Motley Fool
Topics Intellectual Property
Why Top 3% Stock TG Therapeutics Crashed Despite Raising Its 2025 Outlook
August 04, 2025
Via Investor's Business Daily
Traders are paying attention to the gapping stocks in Monday's session.
August 04, 2025
Via Chartmill
TG Therapeutics Inc (NASDAQ:TGTX) Reports Mixed Q2 2025 Results, Raises Full-Year BRIUMVI Revenue Guidance
August 04, 2025
Via Chartmill
TG THERAPEUTICS INC (NASDAQ:TGTX) – A High Growth Momentum Stock with Strong Technical Setup
July 17, 2025
Via Chartmill
TG THERAPEUTICS INC (NASDAQ:TGTX) - A High-Growth Stock Meeting Minervini's Trend Template
July 12, 2025
Via Chartmill
Cramer Backs This Mining Giant After $1.6B Bet
July 01, 2025
Via Benzinga
TG THERAPEUTICS INC (NASDAQ:TGTX) - A High Growth Momentum Stock with Strong Technical Setup
June 25, 2025
Via Chartmill
TG Therapeutics Boosts Retail Sentiment With Q1 Revenue Beat Even As Stock Tumbles On Profit Miss, Conservative Outlook
May 05, 2025
Via Stocktwits
TG Therapeutics Falls Short On Earnings, But Briumvi Sales Steal the Show
May 05, 2025
Via Benzinga
Why TG Therapeutics Stock Was Tumbling Today
May 05, 2025
Via The Motley Fool
Crude Oil Falls Over 2%; ISM Services PMI Rises In April
May 05, 2025
Via Benzinga
TG Therapeutics Stock Tumbles After Q1 Earnings Fall Short Of Wall Street Estimates: But Retail’s Optimistic
May 05, 2025
Via Stocktwits
Applying Mark Minervini’s growth stock checklist to TG THERAPEUTICS INC (NASDAQ:TGTX)
May 02, 2025
Via Chartmill
TG Therapeutics Inc (NASDAQ:TGTX): A Strong Minervini Trend Template Candidate
May 01, 2025
Via Chartmill

Frequently Asked Questions

Is TG Therapeutics, Inc. - Common Stock publicly traded?
Yes, TG Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does TG Therapeutics, Inc. - Common Stock trade on?
TG Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for TG Therapeutics, Inc. - Common Stock?
The ticker symbol for TG Therapeutics, Inc. - Common Stock is TGTX on the Nasdaq Stock Market
What is the current price of TG Therapeutics, Inc. - Common Stock?
The current price of TG Therapeutics, Inc. - Common Stock is 34.14
When was TG Therapeutics, Inc. - Common Stock last traded?
The last trade of TG Therapeutics, Inc. - Common Stock was at 10/14/25 04:00 PM ET
What is the market capitalization of TG Therapeutics, Inc. - Common Stock?
The market capitalization of TG Therapeutics, Inc. - Common Stock is 5.27B
How many shares of TG Therapeutics, Inc. - Common Stock are outstanding?
TG Therapeutics, Inc. - Common Stock has 5B shares outstanding.
Recent Quotes
View More
Symbol Price Change (%)
GOOG  246.19
+1.55 (0.63%)
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap